OTC Markets EXMKT - Delayed Quote USD

Veradigm Inc. (MDRX)

4.3000
+0.1000
+(2.38%)
At close: May 9 at 3:19:56 PM EDT
Loading Chart for MDRX
  • Previous Close 4.2000
  • Open 4.4000
  • Bid --
  • Ask --
  • Day's Range 4.2100 - 4.4000
  • 52 Week Range 3.8000 - 11.8000
  • Volume 567
  • Avg. Volume 216,581
  • Market Cap (intraday) 465.54M
  • Beta (5Y Monthly) 0.77
  • PE Ratio (TTM) --
  • EPS (TTM) -0.1800
  • Earnings Date Mar 18, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date Oct 7, 2008
  • 1y Target Est 8.17

Veradigm Inc., a healthcare technology company, provides information technology solutions to healthcare providers, payers, and biopharma markets in the United States and internationally. The company offers solutions to healthcare providers, comprising practice management software, AI patient scheduling software, and electronic statements and payments, and payerpath clearinghouse; revenue cycle services and coding services; electronic health records solutions, which include eprescribe with EPCS, EHR software, veradigm EHR, and practice fusion EHR; and patient engagement platform. It also provides solutions to network partners, which comprise API connectivity solutions, such as veradigm connect, veradigm app expo, and diagnostic ordering and resulting network; life sciences, health plans and payers, and providers; and veradigm eprescribe enterprise. In addition, the company offers risk adjustment solutions, such as health equity analytics, risk adjustment analytics, risk mitigator, comprehensive submissions, and utilization analytics; quality analytics, risk adjustment, and quality management; data exchange and coding solutions, including echart courier, echart coder, and echart integration and analytics; clinical data registries for physicians and veradigm payer insights; provider engagement solutions; care gap alerting, gap closure services, and veradigm payerpath solutions. Further, it provides real world data solutions, such as NLP-enriched EHR data solutions, and clinical data registries; real world evidence and real-world evidence analytics platform; and digital health media solutions. The company was formerly known as Allscripts Healthcare Solutions, Inc. and changed its name to Veradigm Inc. in January 2023. Veradigm Inc. was founded in 1986 and is headquartered in Chicago, Illinois.

veradigm.com

2,450

Full Time Employees

December 31

Fiscal Year Ends

Recent News: MDRX

View More

Performance Overview: MDRX

Trailing total returns as of 5/9/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

MDRX
55.90%
S&P 500 (^GSPC)
3.77%

1-Year Return

MDRX
44.52%
S&P 500 (^GSPC)
8.55%

3-Year Return

MDRX
76.27%
S&P 500 (^GSPC)
41.81%

5-Year Return

MDRX
32.81%
S&P 500 (^GSPC)
93.18%

Compare To: MDRX

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: MDRX

View More

Valuation Measures

Annual
As of 5/9/2025
  • Market Cap

    465.54M

  • Enterprise Value

    238.39M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.82

  • Price/Book (mrq)

    0.46

  • Enterprise Value/Revenue

    0.41

  • Enterprise Value/EBITDA

    4.08

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -14.70%

  • Return on Assets (ttm)

    -0.62%

  • Return on Equity (ttm)

    -1.69%

  • Revenue (ttm)

    588.02M

  • Net Income Avi to Common (ttm)

    -20.04M

  • Diluted EPS (ttm)

    -0.1800

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    492.6M

  • Total Debt/Equity (mrq)

    18.59%

  • Levered Free Cash Flow (ttm)

    121.33M

Research Analysis: MDRX

View More

Company Insights: MDRX

Research Reports: MDRX

View More

People Also Watch